)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Metropolis Healthcare
Metropolis Healthcare (METROPOLIS) investor relations material
Metropolis Healthcare Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary4 Nov, 2026
Executive summary
H1 FY27 revenue rose 16.2% YoY to ₹9,470.36 million, ahead of guidance; reported EBITDA grew 25.3% to ₹248.2 crore and PAT rose 34.9% to ₹132.4 crore.
Q2 growth was broad-based and volume-led, supported by richer mix, channel and regional breadth, and expansion in TruHealth and Specialty.
Financial highlights
Q2 FY27 revenue was ₹4,968.21 million, versus ₹4,291.91 million a year earlier; profit for the period was ₹754.83 million.
Q2 reported EBITDA was ₹134.9 crore (+23.9% YoY), while PAT was ₹75.5 crore (+42.7%).
H1 reported EBITDA margin expanded 190 bps to 26.2%; PAT margin rose 200 bps to 14.0%.
Mid-teen H1 revenue growth was delivered without price increases, supported by demand and higher patient and test volumes.
Outlook and guidance
Management expects H2 revenue growth and margin expansion to remain near H1 levels.
Medium-term margin gains are supported by operating leverage, productivity, lab-platform transition and technology initiatives.
Selective B2C price revisions are under evaluation; FY27 CapEx is expected at ₹65–70 crore.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Metropolis Healthcare
- Record FY21 results as COVID testing and non-COVID recovery lifted growth.METROPOLIS
Q4 20/21 - COVID normalization cut earnings, while core growth and network expansion advanced.METROPOLISQ4 22/23
- Revenue grew 12.42% as COVID testing and cost controls helped navigate disruption.METROPOLISQ4 19/20
- FY19 revenue grew 17.5% as patient visits, network reach and retail expansion powered growth.METROPOLISQ4 18/19
- Record FY 2021-22 results and 35% non-COVID growth fuel an expansion-led strategy.METROPOLISQ4 21/22
- Strong growth and margin expansion driven by specialty testing, technology, and network scale.METROPOLISInvestor presentation
- Q1 FY27 revenue rose 17% to INR 450 crore, with EBITDA and PAT up over 25% each.METROPOLISQ1 26/27
- Acquisition of Core Diagnostics accelerates oncology leadership and expands reach in key regions.METROPOLISInvestor Update
- FY26 revenue growth guided at 25-26% with margin expansion and strong B2C momentum.METROPOLISQ4 24/25
Next Metropolis Healthcare earnings date
Q3 26/274 Feb, 2027
Metropolis Healthcare
Next Metropolis Healthcare earnings date
Q3 26/274 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Metropolis Healthcare is an India-based diagnostics company that provides pathology and laboratory testing services. The company offers a wide range of clinical laboratory tests across specialties such as biochemistry, hematology, microbiology, molecular diagnostics, and cytogenetics. It operates a network of diagnostic centers and collection facilities serving hospitals, clinics, corporate clients, and individual patients. Metropolis Healthcare also provides specialized testing services and preventive health check-up packages. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.